FSD PHARMA INC-CLASS B (HUGE) Stock Price, Forecast & Analysis
USA - NASDAQ:HUGE - CA35954B4047 - Common Stock
HUGE Key Statistics, Chart & Performance
The current stock price of HUGE is 0.0899 USD. In the past month the price decreased by -40.82%. In the past year, price decreased by -93.22%.
HUGE Latest News, Press Relases and Analysis
HUGE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 42.04 | 874.88B | ||
| JNJ | JOHNSON & JOHNSON | 17.97 | 449.32B | ||
| MRK | MERCK & CO. INC. | 9.79 | 215.51B | ||
| PFE | PFIZER INC | 7.63 | 138.90B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.12 | 95.03B | ||
| ZTS | ZOETIS INC | 18.97 | 53.29B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.38 | 22.49B | ||
| VTRS | VIATRIS INC | 4.34 | 11.80B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.39 | 10.68B | ||
| CORT | CORCEPT THERAPEUTICS INC | 83.77 | 7.77B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.89B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 3.77B |
Related stock screener links
About HUGE
Company Profile
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
Company Info
FSD PHARMA INC-CLASS B
55 University Ave. , Suite 1003
TORONTO ONTARIO M5X 1A4 CA
CEO: Raza Bokhari
Employees: 10
Phone: 14168548884
FSD PHARMA INC-CLASS B / HUGE FAQ
Can you describe the business of FSD PHARMA INC-CLASS B?
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
Can you provide the latest stock price for FSD PHARMA INC-CLASS B?
The current stock price of HUGE is 0.0899 USD. The price decreased by -10.1% in the last trading session.
What is the dividend status of FSD PHARMA INC-CLASS B?
HUGE does not pay a dividend.
How is the ChartMill rating for FSD PHARMA INC-CLASS B?
HUGE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Should I buy HUGE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HUGE.
How many employees does FSD PHARMA INC-CLASS B have?
FSD PHARMA INC-CLASS B (HUGE) currently has 10 employees.
What is the market capitalization of HUGE stock?
FSD PHARMA INC-CLASS B (HUGE) has a market capitalization of 3.64M USD. This makes HUGE a Nano Cap stock.
HUGE Technical Analysis
HUGE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HUGE Forecast & Estimates
7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.